Published on 22 Oct 2023 on Zacks · via Yahoo Finance
Pliant Therapeutics, Inc. (PLRX) Soars 14.3%: Is Further Upside Left in the...
Pliant Therapeutics, Inc. PLRX shares ended the last trading session 14.3% higher at $16.67. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.9% loss over the past four weeks.
Share price surged as the company announced that its mid stage INTEGRIS-PSC study on lead pipeline candidate, bexotegrast for patients with primary sclerosing cholangitis, met its primary and secondary endpoints. The study demonstrated that the candidate was well tolerated over a 12-week treatment period and its plasma concentrations increased with dose.